MiRagen Therapeutics Garners $20,000,000 Series B Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a9d85271-704c-40c7-963f-afbf0641b017&Preview=1 - Date
4/24/2012 - Company Name
MiRagen Therapeutics - Mailing Address
6200 Lookout Rd Boulder, CO 80301 - Company Description
Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease. - Website
http://www.miragentherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$20,000,000 - Transaction Round
Series B - Proceeds Purposes
The funding enables miRagen to advance the development of its compelling microRNA-based therapeutics pipeline. - M&A Terms
- Venture Investor
Remeditex Ventures - Venture Investor
Atlas Venture - Venture Investor
Boulder Ventures - Venture Investor
Amgen Ventures - Venture Investor
Broadview Ventures
